NasdaqGM - Nasdaq Real Time Price USD
Acrivon Therapeutics, Inc. (ACRV)
At close: November 6 at 4:00 PM EST
After hours: November 6 at 6:31 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-53,158.00
-42,641.00
-30,117.00
-13,982.00
-2,803.00
Investing Cash Flow
-60,142.00
50,717.00
-141,676.00
-238.00
-15.00
Financing Cash Flow
121,245.00
-1,554.00
101,709.00
112,221.00
2,889.00
End Cash Position
46,427.00
36,429.00
29,907.00
99,991.00
1,990.00
Capital Expenditure
-2,103.00
-1,288.00
-2,166.00
-238.00
-15.00
Issuance of Capital Stock
69,997.00
--
104,458.00
112,220.00
2,831.00
Issuance of Debt
--
--
--
--
58.00
Free Cash Flow
-55,261.00
-43,929.00
-32,283.00
-14,220.00
-2,818.00
12/31/2020 - 11/15/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RAPP Rapport Therapeutics, Inc.
26.15
+13.55%
ARTV Artiva Biotherapeutics, Inc.
14.47
+21.60%
IMTX Immatics N.V.
9.19
-1.82%
ANL Adlai Nortye Ltd.
2.3200
+2.20%
ALMS Alumis Inc.
12.34
+3.26%
BCYC Bicycle Therapeutics plc
23.64
+0.55%
BOLD Boundless Bio, Inc.
3.1700
+6.02%
CLYM Climb Bio, Inc.
3.6500
+0.83%
SWTX SpringWorks Therapeutics, Inc.
33.00
+4.46%
CGEM Cullinan Therapeutics, Inc.
16.48
+3.13%